-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, the German specialty chemicals giant Evonik announced the injection of Fuhua Angel Investment Fund and Woyan Capital Phase III Venture Capital Fund
.
Through this investment, Evonik will expand its venture capital activities in China and deepen its insight into emerging technologies and business opportunities
The Fuhua Angel Investment Fund (GRC) mainly invests in green technology materials companies in China.
The target industries include circular economy, synthetic biology, 3D printing, battery materials, carbon materials and other fields
.
This investment is an additional investment after Evonik invested in the GRC Phase III Fund in 2015
Woyan Capital focuses on new chemical materials as its main investment direction, while focusing on emerging technology fields such as high-end equipment and digital technology
.
Its investment strategy focuses on the value chain of "materials-equipment-data", and target industries include strategic emerging industries such as pan-semiconductors, electric vehicles, digital manufacturing, 5G and alternative energy
Xia Fuliang, President of Evonik Greater China, said: "The investment fields of these two venture capital funds are highly related to the growth industries that Evonik focuses on in China.
They will create good opportunities for us to accelerate product development and develop new business models
.
"
It is reported that Evonik's venture capital department has established a local team in Shanghai since 2018 and has become a well-known corporate venture capital (CVC) partner in the specialty chemicals field
.
Prior to this, Evonik has completed multiple fund investments and direct investments
Evonik is a specialty chemicals company with operations in more than 100 countries and regions.
In fiscal 2020, Evonik’s sales were 12.
2 billion euros
.
Evonik's venture capital department helps companies acquire disruptive technologies and innovative business models, and provides support for digital transformation